The SBIR STTR reauthorization bill of 2028, introduced by Senator Joni Ernst, proposes to extend two of the most impactful federal funding programs for small business innovation. If passed, it will ensure continued support for cutting-edge research and technology development…
NSF Phase II Solid-State Battery Grant Awarded to Piersica NSF Phase II solid-state battery grant — We are thrilled to congratulate our client, Piersica, Inc., on securing a $1 million Phase II grant from the National Science Foundation (NSF). This…
Key Highlights from the Harvard Non-Dilutive Funding Workshop Harvard non-dilutive funding workshop — This week, our CEO Alfredo Sánchez delivered an insightful session at the Harvard Innovation Lab focused on Grants and Other Non-Dilutive Funding. The event was a highlight…
Personalized Medicine Research: How Sanguine Biosciences and Inspiralia Drive Innovation Personalized medicine research is reshaping the future of healthcare. At Inspiralia, we’re proud to have supported Sanguine Biosciences Inc., a former client, in their mission to revolutionize medical research through…
Virtual Reality Surgical Training: Osso VR’s Growth with Inspiralia Virtual reality surgical training is reshaping how medical professionals develop critical skills. At Inspiralia, we take pride in working with innovative companies like Osso VR, a former client revolutionizing surgical training…
Cardiovascular monitoring technology plays a crucial role in modern healthcare. At Inspiralia, we’re proud to support InteloMed Inc. and their cutting-edge solution, CVInsight®. This non-invasive monitoring system delivers real-time cardiovascular insights, empowering clinicians to make faster, more informed decisions that…
Autism Therapy Technology: iTherapy’s Breakthrough with Inspiralia Autism therapy technology is evolving, and at Inspiralia, we’re proud to contribute to innovations that improve lives. One remarkable success story is our partnership with iTherapy LLC, a company redefining autism support through…